Previous Page Next Page

Reactive management of hair changes induced by multikinase inhibitor treatment

General recommendation: Excessive hair growth and alopecia can cause embarrassment and psychological distress. Patients can be reassured that, in most cases, hair growth will normalise after completion of treatment.1

Treatment overview

Non-scarring alopecia may occur after 2-3 months of treatment and usually resolves after discontinuation of treatment, although altered hair regrowth is sometimes observed.2, 3 Minoxidil is used to treat non-scarring alopecia in the general population.2 If given to patients receiving targeted therapy, pruritus and hypertrichosis should be monitored.2

Table 34. Management of hair changes associated with multikinase inhibitors1-3

Management of hair changes

Alopecia, non-scarring

  • Minoxidil 2% or 5% bid

Alopecia, scarring

  • Class 1 steroid lotion, shampoo, or foam
  • Antibiotic lotion

Products

  • Minoxidil 2% or 5% twice daily
  • Steroid lotion, shampoo or foam
  • Eflornithine

Multikinase inhibitor treatment

Continue with/withhold the selected multikinase inhibitor treatment regimen, as recommended in the current and relevant SPC and according to the patient’s condition.

References

  1. Boers-Doets CB. The TARGET SYSTEM. Approach to assessment, grading, and management of dermatological & mucosal side effects of targeted anticancer therapies. ISBN 978-94-92070-00-5. 2014.
  2. Lacouture ME, et al. MASCC Skin Toxicity Study Group. Support Care Cancer. 2011; 19: 1079-95.
  3. Suchonwanit P. and McMichael A.J. Am J of Clin Dermatol. 2018; 19:853-865.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings